Longitudinal trends in base antiretroviral therapy utilization for human immunodeficiency virus from 2000 to 2016-Reference-Cited by-同舟云学术

Longitudinal trends in base antiretroviral therapy utilization for human immunodeficiency virus from 2000 to 2016

Published:2018-06-28 Issue:1 Volume:2 Page:32-39
ISSN:2574-9870
Container-title:Journal of the American College of Clinical Pharmacy
language:en
Short-container-title:J Am Coll Clin Pharm

Author:

Magagnoli Joseph¹,Sutton S. Scott¹²^ORCID,Hardin James W.¹³,Edun Babatunde⁴

Affiliation:

1. WJB Dorn Veterans Affairs Medical Center; Dorn Research Institute; Columbia South Carolina

2. Department of Clinical Pharmacy and Outcomes Sciences; South Carolina College of Pharmacy, University of South Carolina; Columbia South Carolina

3. Department of Epidemiology & Biostatistics; University of South Carolina; Columbia South Carolina

4. WJB Dorn Veterans Affairs Medical Center, Division of Infectious Diseases; Columbia South Carolina

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jac5.1016/fullpdf

Reference30 articles.

1. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

2. Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study;Molina;Lancet HIV,2015

3. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection;Walmsley;N Engl J Med,2013

4. The NEAT study: A 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients;Rodriguez-French;J Acquir Immune Defic Syndr,2004

5. SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients;Gathe;AIDS,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of single tablet regimen on prescription trends for treatment-naïve patients with HIV/AIDS in Korea;Scientific Reports;2022-02-07

2. Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort;Clinical Infectious Diseases;2022-02-03